|
IRF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.718200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.796970E-01 |
| Normal-vs-Stage2 |
2.768300E-02 |
| Normal-vs-Stage3 |
5.615800E-03 |
| Normal-vs-Stage4 |
9.175900E-03 |
| Stage1-vs-Stage2 |
1.196760E-01 |
| Stage1-vs-Stage3 |
2.332400E-02 |
| Stage1-vs-Stage4 |
5.518100E-02 |
| Stage2-vs-Stage3 |
9.210600E-01 |
| Stage2-vs-Stage4 |
8.147200E-01 |
| Stage3-vs-Stage4 |
8.650800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.360200E-02 |
| Normal-vs-AfricanAmerican |
2.394600E-01 |
| Normal-vs-Asian |
4.970200E-01 |
| Caucasian-vs-AfricanAmerican |
8.137200E-01 |
| Caucasian-vs-Asian |
2.234200E-01 |
| AfricanAmerican-vs-Asian |
5.710600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.219600E-02 |
| Normal-vs-Female |
2.897800E-02 |
| Male-vs-Female |
7.648600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.041400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.355500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.584730E-03 |
| Normal-vs-Age(81-100Yrs) |
8.869500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.774000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.365730E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.731600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.612100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.632800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.562800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.209400E-01 |
| Classical-VS-Follicular |
1.355610E-02 |
| Classical-VS-Other |
9.264600E-01 |
| Classical-VS-Normal |
1.574250E-01 |
| Tall-VS-Follicular |
5.651200E-01 |
| Tall-VS-Other |
6.237600E-01 |
| Tall-VS-Normal |
5.889800E-02 |
| Follicular-VS-Other |
4.874800E-01 |
| Follicular-VS-Normal |
6.237100E-03 |
| Other-VS-Normal |
5.678000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.717500E-02 |
| Normal-vs-N1 |
4.383600E-03 |
| N0-vs-N1 |
1.064780E-01 |
|
|
